Skip to content

Clinical trials

Sarcoma, Kaposi trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma, Kaposi Country / region: United States Clear all

113 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20016
20022
20032
20041
20053
20063
20072
20082
20091
20104
20112
20121
20144
20151
20162
20173
20181
20202
20215
20221
20234
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed85
Recruiting13
Terminated9
Active, not recruiting3
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)33
National Institute of Allergy and Infectious Diseases (NIAID)17
AIDS Malignancy Consortium10
Daiichi Pharmaceuticals4
Memorial Sloan Kettering Cancer Center4
Sequus Pharmaceuticals4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
University of California, San Francisco3
Washington University School of Medicine3
Case Comprehensive Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma, Kaposi113
HIV Infections54
Acquired Immunodeficiency Syndrome52
Sarcoma28
Neoplasms17
Lymphoma, Non-Hodgkin10
Skin Neoplasms10
Lymphoma8
Melanoma8
Lung Neoplasms7

Trials

Showing 1 to 25 of 113. Each trial links to its page on Pharma Observatory.

13 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.